```json
{
"content": [
{
"type": "paragraph",
"content": "The Anti-adhesion Gel for Medical market encompasses bioengineered formulations designed to prevent post-surgical adhesions, reducing complications and hospital readmissions. With the global market size estimated at $1.2 billion in 2023, the growth outlook remains robust, driven by rising surgical volumes and advancements in minimally invasive procedures. This market forecast underscores an industry expansion at a compound annual growth rate (CAGR) of 6.5% from 2026 to 2033, fueled by increasing demand for bioabsorbable materials and regulatory support for adhesion prevention products."
},
{
"type": "chart",
"chartType": "segment-stacked",
"data": {
"segments": ["Carboxymethylcellulose (CMC)", "Hyaluronic Acid (HA)", "Others"],
"periods": ["2021", "2022", "2023", "2024", "2025", "2026", "2027", "2028", "2029", "2030", "2031", "2032", "2033"],
"values": [
[250, 270, 290, 310, 330, 350, 375, 400, 425, 450, 475, 500, 525, 550], // CMC
[150, 160, 170, 180, 190, 200, 215, 230, 245, 260, 275, 290, 305, 320], // HA
[50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100, 105, 110, 115] // Others
]
}
},
{
"type": "paragraph",
"content": "Key forces shaping the industry include technological shifts toward synthetic polymer-based gels with enhanced biocompatibility and regulatory tailwinds supporting adhesion prevention in high-risk surgeries. North America dominates the market due to early adoption of advanced medical devices, while Asia-Pacific is the fastest-growing region, driven by expanding healthcare infrastructure and rising surgical demand. Competitive intensity is moderated by patent expirations, enabling new entrants to innovate in cost-effective formulation spaces."
}
]
}
```
